Wednesday, January 29th, 2025

Category: US stocks

US stocks

Why Betting on Rate Predictions Could Cost You: The Smarter Path to Investment Success

In the unpredictable world of investing, 2024 proved to be a year where reality defied expectations, leaving many market forecasters red-faced. Despite widespread predictions of dire consequences tied to interest-rate forecasts, the S&P 500...

Morningstar’s 10 Cheapest Wide-Moat US Stocks for 2025: Estee Lauder, Pfizer, Nike Lead the Pack

Morningstar Equity Research has unveiled its 10 “cheap, wide-moat” US stocks for 2025, spotlighting companies with strong competitive advantages that enable them to fend off rivals and deliver long-term value to investors. What Are...

2025 Crystal Ball: Predictions for the Year Ahead in Politics, Tech, and the Global Economy

The dawn of 2025 brings bold forecasts spanning geopolitics, economics, and pop culture. From tariff wars and peace deals to the future of AI and vinyl’s shiny cousin, CDs, here’s what experts predict will...

2025 Commodities Forecast: Brace for Skyrocketing Coffee Prices and Tumultuous Oil Markets

As the calendar turns to 2025, consumers and investors alike should prepare for turbulence across commodity markets, with coffee, oil, and other staples poised for significant shifts driven by geopolitics and weather disruptions. Coffee:...

Wall Street’s Champions: 2024’s Top 10 Stocks That Redefined Success

As 2024 nears its end, the financial markets have crowned the top performers of the S&P 500. From tech giants riding the artificial intelligence wave to energy companies powering the data-driven future, here’s a...

Elon Musk’s Support for Weight-Loss Drugs Could Propel Eli Lilly Stock: Analysts See 40% Upside

A Presidential Boost for GLP-1s? Eli Lilly’s stock, recently hit by postelection volatility, could see a remarkable turnaround, driven in part by high-profile endorsements. Bernstein analysts point to positive signals that suggest the pharmaceutical...

Anteris Technologies IPO: A Game-Changer in Heart Valves, Oversubscribed by 9x

1. IPO Details Purpose of IPO: Anteris Technologies plans to use IPO proceeds to advance R&D for its flagship DurAVR transcatheter heart valve, expand production facilities, and boost global commercialization. Approximately $100 million of...

Biotech Sector Rebounds: FDA Approvals Surge and Amgen (AMGN) Shows Promise in 2024

Intermediate Term Market Outlook: December 2024 Intermediate Term Market Outlook: December 2024 Broker Name: Argus Research Co. Date of Report: Tuesday, December 10, 2024 Market Overview The market outlook for the intermediate term remains...

JPMorgan Chase Earns Top Marks: S&P Upgrades Credit Rating Amid Strong Performance

JPMorgan Chase Earns Top Marks: S&P Upgrades Credit Rating Amid Strong Performance In a major vote of confidence for JPMorgan Chase & Co., S&P Global Ratings has upgraded the bank’s long-term issuer credit rating...

Investors should not fear a stock market crash

Stocks may seem risky in the short term, but they are less volatile over the long run than many people think. In fact, stocks share some characteristics with bonds, which makes them more predictable....